Your browser doesn't support javascript.
loading
A Case of Sitagliptin Induced DRESS Syndrome / 대한피부과학회지
Korean Journal of Dermatology ; : 330-333, 2020.
Article | WPRIM | ID: wpr-832708
ABSTRACT
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is an adverse drug reaction that is difficult to predict. It is characterized by fever, skin rash, and internal organ involvement that usually manifests 2∼6 weeks after use of the culprit drug. The antihyperglycemic agent sitagliptin is commonly used for treating diabetes mellitus, and sitagliptin-induced DRESS syndrome has not been previously reported in Korea. Herein, we report a case of DRESS syndrome after sitagliptin use; these observations may contribute to the timely diagnosis of sitagliptin induced DRESS syndrome and help reduce associated complications or morbidities.
Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Texte intégral: Korean Journal of Dermatology Année: 2020 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Texte intégral: Korean Journal of Dermatology Année: 2020 Type: Article